My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 149

    1.

    The peroxisome proliferator-activated receptor-gamma2 Pro12A1a variant: association with type 2 diabetes and trait differences.

    Douglas JA, Erdos MR, Watanabe RM, Braun A, Johnston CL, Oeth P, Mohlke KL, Valle TT, Ehnholm C, Buchanan TA, Bergman RN, Collins FS, Boehnke M, Tuomilehto J.

    Diabetes. 2001 Apr;50(4):886-90.PMID: 11289057 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    [Association of Pro12Ala variant in peroxisome proliferator-activated receptor-gamma2 gene with type 2 diabetes mellitus]

    Fu M, Chen H, Li X, Li J, Wu B, Cheng L, Cai M, Fu Z.

    Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2002 Jun;19(3):234-8. Chinese. PMID: 12048686 [PubMed - indexed for MEDLINE]Related articles

    3.

    Pro12Ala of the peroxisome proliferator-activated receptor-gamma2 gene is associated with lower serum insulin levels in nonobese African Americans: the Atherosclerosis Risk in Communities Study.

    Kao WH, Coresh J, Shuldiner AR, Boerwinkle E, Bray MS, Brancati FL; Atherosclerosis Risk in Communities Study.

    Diabetes. 2003 Jun;52(6):1568-72.PMID: 12765972 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Effect of the peroxisome proliferator-activated receptor-gamma 2 pro(12)ala variant on obesity, glucose homeostasis, and blood pressure in members of familial type 2 diabetic kindreds.

    Hasstedt SJ, Ren QF, Teng K, Elbein SC.

    J Clin Endocrinol Metab. 2001 Feb;86(2):536-41.PMID: 11158005 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Impact of Prol2Ala variant in the peroxisome proliferator-activated receptor (PPAR) gamma2 on obesity and insulin resistance in Japanese Type 2 diabetic and healthy subjects.

    Kawasaki I, Tahara H, Emoto M, Shoji T, Shioji A, Okuno Y, Inaba M, Nishizawa Y.

    Osaka City Med J. 2002 Jun;48(1):23-8.PMID: 12375694 [PubMed - indexed for MEDLINE]Related articles

    6.

    Association of the PRO12ALA polymorphism of the PPAR-gamma2 gene with oxidized low-density lipoprotein and cardiolipin autoantibodies in nondiabetic and type 2 diabetic subjects.

    Niskanen L, Lindi V, Erkkilä A, Sivenius K, Luoma J, Ylä-Herttuala S, Laakso M, Uusitupa MI.

    Metabolism. 2003 Feb;52(2):213-7.PMID: 12601635 [PubMed - indexed for MEDLINE]Related articles

    7.

    Homozygosity of the Pro12Ala variant of the peroxisome proliferation-activated receptor-gamma2 (PPAR-gamma2): divergent modulating effects on body mass index in obese and lean Caucasian men.

    Ek J, Urhammer SA, Sørensen TI, Andersen T, Auwerx J, Pedersen O.

    Diabetologia. 1999 Jul;42(7):892-5.PMID: 10440134 [PubMed - indexed for MEDLINE]Related articles

    8.

    A functional variant in the peroxisome proliferator-activated receptor gamma2 promoter is associated with predictors of obesity and type 2 diabetes in Pima Indians.

    Muller YL, Bogardus C, Beamer BA, Shuldiner AR, Baier LJ.

    Diabetes. 2003 Jul;52(7):1864-71.PMID: 12829658 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Pro12Ala missense mutation of the peroxisome proliferator activated receptor gamma and diabetes mellitus.

    Ringel J, Engeli S, Distler A, Sharma AM.

    Biochem Biophys Res Commun. 1999 Jan 19;254(2):450-3.PMID: 9918859 [PubMed - indexed for MEDLINE]Related articles

    10.

    A Pro12Ala polymorphism in the human peroxisome proliferator-activated receptor-gamma 2 is associated with combined hyperlipidaemia in obesity.

    Swarbrick MM, Chapman CM, McQuillan BM, Hung J, Thompson PL, Beilby JP.

    Eur J Endocrinol. 2001 Mar;144(3):277-82.PMID: 11248748 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    The human peroxisome proliferator-activated receptor gamma2 (PPARgamma2) Pro12Ala polymorphism is associated with decreased risk of diabetic nephropathy in patients with type 2 diabetes.

    Caramori ML, Canani LH, Costa LA, Gross JL.

    Diabetes. 2003 Dec;52(12):3010-3.PMID: 14633865 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Studies of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma2 (PPAR-gamma2) gene in relation to insulin sensitivity among glucose tolerant caucasians.

    Ek J, Andersen G, Urhammer SA, Hansen L, Carstensen B, Borch-Johnsen K, Drivsholm T, Berglund L, Hansen T, Lithell H, Pedersen O.

    Diabetologia. 2001 Sep;44(9):1170-6.PMID: 11596673 [PubMed - indexed for MEDLINE]Related articles

    13.

    Association between the Pro12Ala variant of the peroxisome proliferator-activated receptor-gamma2 gene and increased 24-h diastolic blood pressure in obese patients with type II diabetes.

    Stefański A, Majkowska L, Ciechanowicz A, Frankow M, Safranow K, Parczewski M, Moleda P, Pilarska K.

    J Hum Hypertens. 2006 Sep;20(9):684-92. Epub 2006 Apr 20.PMID: 16625233 [PubMed - indexed for MEDLINE]Related articles

    14.

    Pro12Ala polymorphism in the peroxisome proliferator-activated receptor-gamma2 (PPARgamma2) is associated with higher levels of total cholesterol and LDL-cholesterol in male caucasian type 2 diabetes patients.

    Zietz B, Barth N, Spiegel D, Schmitz G, Schölmerich J, Schäffler A.

    Exp Clin Endocrinol Diabetes. 2002 Apr;110(2):60-6.PMID: 11928067 [PubMed - indexed for MEDLINE]Related articles

    15.

    Fasting plasma free fatty acid concentrations and Pro12Ala polymorphism of the peroxisome proliferator-activated receptor (PPAR) gamma2 gene in healthy individuals.

    Vaccaro O, Mancini FP, Ruffa G, Sabatino L, Iovine C, Masulli M, Colantuoni V, Riccardi G.

    Clin Endocrinol (Oxf). 2002 Oct;57(4):481-6.PMID: 12354130 [PubMed - indexed for MEDLINE]Related articles

    16.

    Peroxisome proliferator-activated receptor-gamma2 polymorphism Pro12Ala is associated with nephropathy in type 2 diabetes: The Berlin Diabetes Mellitus (BeDiaM) Study.

    Herrmann SM, Ringel J, Wang JG, Staessen JA, Brand E; Berlin Diabetes Mellitus (BeDiaM) Study.

    Diabetes. 2002 Aug;51(8):2653-7.PMID: 12145184 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Impact of the Peroxisome Proliferator Activated Receptor gamma2 Pro12Ala polymorphism on adiposity, lipids and non-insulin-dependent diabetes mellitus.

    Meirhaeghe A, Fajas L, Helbecque N, Cottel D, Auwerx J, Deeb SS, Amouyel P.

    Int J Obes Relat Metab Disord. 2000 Feb;24(2):195-9.PMID: 10702770 [PubMed - indexed for MEDLINE]Related articles

    18.

    A possible association of Pro12Ala polymorphism in peroxisome proliferator-activated receptor gamma2 gene with obesity in native Javanese in Indonesia.

    Danawati CW, Nagata M, Moriyama H, Hara K, Yasuda H, Nakayama M, Kotani R, Yamada K, Sakata M, Kurohara M, Wiyono P, Asdie H, Sakaue M, Taniguchi H, Yokono K.

    Diabetes Metab Res Rev. 2005 Sep-Oct;21(5):465-9.PMID: 15739197 [PubMed - indexed for MEDLINE]Related articles

    19.

    Pro12Ala substitution in the peroxisome proliferator-activated receptor-gamma2 is not associated with type 2 diabetes.

    Mancini FP, Vaccaro O, Sabatino L, Tufano A, Rivellese AA, Riccardi G, Colantuoni V.

    Diabetes. 1999 Jul;48(7):1466-8.PMID: 10389855 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    The peroxisome proliferator activated receptorgamma2 (PPARgamma2) Pro12Ala variant: lack of association with type 2 diabetes in obese and non obese Tunisian patients.

    Zouari Bouassida K, Chouchane L, Jellouli K, Chérif S, Haddad S, Gabbouj S, Danguir J.

    Diabetes Metab. 2005 Apr;31(2):119-23.PMID: 15959417 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity